文献速递产科麻醉

硬膜外新斯的明与芬太尼用于分娩患者自控硬膜外镇痛以减少布比卡因用量的随机双盲对照研究

Epidural Neostigmine versus Fentanyl to Decrease Bupivacaine Use in Patient-controlled Epidural Analgesia during Labor: A Randomized, Double-blind, Controlled Study.
PubMed 文献 · Anesthesiology · 2017-01-01

该随机双盲对照研究纳入215名ASA II级分娩产妇,比较0.125%布比卡因分别联合芬太尼(2 μg/ml)或新斯的明(2、4、8 μg/ml)用于患者自控硬膜外镇痛。主要结局为每小时局部麻醉药总用量,结果显示各组间无差异(P=0.55),芬太尼组中位每小时布比卡因用量为16.0 ml/h,新斯的明2、4、8 μg/ml组分别为15.3、14.6、16.2 ml/h。结论不支持新斯的明与芬太尼在布比卡因需求上存在差异。

要点

  • 硬膜外新斯的明(2–8 μg/ml)与芬太尼(2 μg/ml)相比,每小时布比卡因用量无显著差异。
  • 芬太尼组中位每小时布比卡因用量为16.0 ml/h,新斯的明各组为15.3、14.6、16.2 ml/h。
  • 主要结局每小时局部麻醉药总用量组间比较P=0.55。

核心结论

  • 数据不支持硬膜外新斯的明(2–8 μg/ml)与芬太尼(2 μg/ml)在分娩患者自控硬膜外镇痛布比卡因需求量上存在差异。

研究设计与样本

  • 随机、双盲、对照研究,共215名ASA II级分娩产妇同意参与,最终151例可评估。
  • 产妇随机接受0.125%布比卡因联合芬太尼(2 μg/ml)或新斯的明(2、4、8 μg/ml)。
  • 主要结局为每小时局部麻醉药总用量,即患者自控硬膜外镇痛总用量与追加量之和(以0.125%布比卡因毫升数表示)除以输注时间。
  • 先验分析确定每组需35例,在α=0.05时以80%把握度检测主要结局20%的差异。

主要发现

  • 各组人口学特征、母婴结局及分娩特征相似。
  • 每小时局部麻醉药总用量组间无差异(P=0.55)。
  • 芬太尼组中位每小时布比卡因用量为16.0 ml/h,新斯的明2、4、8 μg/ml组分别为15.3、14.6、16.2 ml/h(P=0.55)。

临床怎么用

  • 对于分娩患者自控硬膜外镇痛,硬膜外新斯的明(2–8 μg/ml)并未显示出比芬太尼(2 μg/ml)减少布比卡因每小时用量的优势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The addition of opioids to epidural local anesthetic reduces local anesthetic consumption by 20% but at the expense of side effects and time spent for regulatory compliance paperwork. Epidural neostigmine also reduces local anesthetic use. The authors hypothesized that epidural bupivacaine with neostigmine would decrease total hourly bupivacaine use compared with epidural bupivacaine with fentanyl for patient-controlled epidural analgesia. METHODS: A total of 215 American Society of Anesthesiologists physical status II, laboring parturients requesting labor epidural analgesia consented to the study and were randomized to receive 0.125% bupivacaine with the addition of either fentanyl (2 μg/ml) or neostigmine (2, 4, or 8 μg/ml). The primary outcome was total hourly local anesthetic consumption, defined as total patient-controlled epidural analgesia use and top-ups (expressed as milliliters of 0.125% bupivacaine) divided by the infusion duration. A priori analysis determined a group size of 35 was needed to have 80% power at α = 0.05 to detect a 20% difference in the primary outcome. RESULTS: Of 215 subjects consented, 151 patients were evaluable. Demographics, maternal and fetal outcomes, and labor characteristics were similar among groups. Total hourly local anesthetic consumption did not differ among groups (P = 0.55). The total median hourly bupivacaine consumption in the fentanyl group was 16.0 ml/h compared with 15.3, 14.6, and 16.2 ml/h in the 2, 4, and 8 μg/ml neostigmine groups, respectively (P = 0.55). CONCLUSIONS: The data do not support any difference in bupivacaine requirements for labor patient-controlled epidural analgesia whether patients receive epidural bupivacaine with 2 to 8 μg/ml neostigmine or epidural bupivacaine with 2 μg/ml fentanyl.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Booth JL, Ross VH, Nelson KE, et al. Epidural Neostigmine versus Fentanyl to Decrease Bupivacaine Use in Patient-controlled Epidural Analgesia during Labor: A Randomized, Double-blind, Controlled Study. Anesthesiology. 2017. PMID: 28475555. doi:10.1097/ALN.0000000000001669

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。